The present invention relates to long acting glucagon-like peptide-1 and human glucose-dependent insulinotropic polypeptide (GIP) agonist polypeptides which may be useful for treating type 2 diabetes mellitus (T2D), diabetes with obesity, obesity and hyperlipidemia.
本发明涉及长效的胰高血糖素样肽-1和人类
葡萄糖依赖性
胰岛素增敏肽(GIP)激动剂肽,可用于治疗2型糖尿病(T2D),伴有肥胖的糖尿病,肥胖和高脂血症。